International Journal of Pharmaceutical Investigation, 2019, 9, 3, 89-92.
DOI: 10.5530/ijpi.2019.3.18
Published: November 2019
Type: Review Article
Authors:
Sakib Mosharraf
Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, Bangladesh
Mohammad Salim Hossain
Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, Bangladesh.
Md. Abdul Barek
Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, Bangladesh.
Hrishov Das
Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, Bangladesh
Md. Abdur Rahman Ripon
Department of Pharmacy, Noakhali Science and Technology University, Sonapur, Noakhali, Bangladesh.
ABSTRACT
Pharmaceutical is the core of Bangladesh’s Healthcare sector with an annual average growth rate consistently in the double digits. The real growth of local pharmaceutical industries started after the “Drug Control Ordinance-1982’’. This research is based on Primary and secondary data. Presently, the industry meets 97% of local demand and exports to more than 80 countries. Generic drugs in Bangladesh estimates to reach BDT 30,300 core by 2024. A local industry supporting drug policy and effective regulatory framework, along with trade related aspects of intellectual property rights relaxations are the key reasons for success of the industry. Prime Minister Sheikh Hasina has named pharmaceuticals the Product of the Year for 2018. Prospect of the sector depends largely on the interactions among the proprietors, regulatory bodies and the government, whether they can meet up the requisites to continue growth of the sector while facing the challenge.
Keywords: Pharmaceutical, Generic, Trade, Drug policy, Prospect.